HCWB:NASDAQ, HCW Biologics Inc.

HCWB stock overview

HCW Biologics Inc. (HCWB:NASDAQ) closed at $0.800 on November 16, 2026, up 3.48% on the day. The stock trades 96.7% below its 52-week high of $23.94 and 7.7% above its 52-week low of $0.743. Over the past year, it lost 94.5%. HCW Biologics Inc. is part of the Health Care sector.

Key figures

Price
$0.800
Day change
+3.48%
Volume
87,029
Average volume
401,128
Market cap
1M+
52-week range
$0.743 – $23.94
50-day average
$1.52
200-day average
$3.78

Price action over the past year

In 252 trading sessions since November 14, 2025, HCWB closed higher on 82 days (33%). Its best day was May 15, 2026 (+262.02%) and its worst was March 23, 2026 (-29.91%). The stock moved 10% or more in a single session 44 times. It opened at least 5% above the previous day's high 4 times.

Recent signals

HCWB news

About HCW Biologics Inc.

HCW Biologics Inc is a preclinical stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between chronic, low-grade inflammation and age-related diseases. It is developing HCW9218 as an injectable immunotherapeutic for patients with solid tumors.

Similar stocks

Find more stocks like HCWB with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.